Literature DB >> 12234056

Release of algesic substances in human experimental muscle pain.

L Tegeder1, J Zimmermann, S T Meller, G Geisslinger.   

Abstract

OBJECTIVE: We employed the 'delayed onset of muscle soreness' (DOMS) and the 'hypertonic saline' muscle pain models in combination with muscle microdialysis to evaluate the role of potentially algesic substances (lactate, glutamate, prostaglandin E2 (PGE2), nitric oxide (NO) and substance P (SP)) in the development of human muscle pain.
METHODS: DOMS was induced by 2 sets of 50 concentric/eccentric contractions of the calf muscles 24 h before the start of microdialysis. During microdialysis pain was stimulated through calf muscle contractions (dorsal and plantar flexions of the foot). Hypertonic saline was injected into the biceps muscle (5 x 200 microl 5.8% NaCl, 2 min interval) during dialysis. The calf (no treatment) and biceps (normal saline) of the other side was used as control.
RESULTS: Both models reliably induced muscle pain with similar intensities as assessed by visual analog scale. The DOMS exercise caused an increase of lactate in serum and the calf muscles of the DOMS leg. In addition, glutamate, PGE2 and substance P dialysate concentrations increased following contraction-induced pain stimulation (peak concentrations 125 +/- 20 microM, 239 +/- 45 pg/ml and 60 +/- 11 pg/ml for glutamate, PGE2 and SP, respectively). This increase did not occur in the control leg (peak concentrations 97 +/- 12 microM, 114 +/- 26 pg/ml and 46 +/- 9 pg/ml for glutamate, PGE2 and SP, respectively). Concentrations of nitric oxide were lower in the DOMS than control leg, particularly during the first 4h of microdialysis. Injection of hypertonic saline into the biceps muscle caused a significant increase of dialysate glutamate concentrations (peak 50 +/- 3 microM) whereas glutamate remained constant after injection of normal saline (mean 26 +/- 1 microM). Injection of hypertonic saline had no effect on lactate, PGE2 or NO levels.
CONCLUSION: Our data support the notion that an inflammatory reaction may be involved in muscle soreness following eccentric exercise, whereas the injection of hypertonic saline into the muscle probably directly stimulates muscle nociceptors and causes glutamate release.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234056     DOI: 10.1007/pl00000320

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  23 in total

Review 1.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

2.  Enhanced temporal summation of pressure pain in the trapezius muscle after delayed onset muscle soreness.

Authors:  Hongling Nie; Lars Arendt-Nielsen; Pascal Madeleine; Thomas Graven-Nielsen
Journal:  Exp Brain Res       Date:  2005-11-23       Impact factor: 1.972

3.  Increased morphine analgesia and reduced side effects in mice lacking the tac1 gene.

Authors:  A Bilkei-Gorzo; J Berner; J Zimmermann; R Wickström; I Racz; A Zimmer
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Delayed muscle onset soreness in the gastrocnemius muscle attenuates the spinal contribution to interlimb communication.

Authors:  Sabata Gervasio; Sara Finocchietti; Andrew J T Stevenson; Natalie Mrachacz-Kersting
Journal:  Eur J Appl Physiol       Date:  2018-08-21       Impact factor: 3.078

Review 5.  Optimising exercise training in peripheral arterial disease.

Authors:  Andrew C Bulmer; Jeff S Coombes
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

6.  Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjects.

Authors:  Lisa Felden; Carmen Walter; Carlo Angioni; Yannick Schreiber; Nils von Hentig; Nerea Ferreiros; Gerd Geisslinger; Jörn Lötsch
Journal:  Pharm Res       Date:  2014-01-28       Impact factor: 4.200

Review 7.  The skeletal muscle arachidonic acid cascade in health and inflammatory disease.

Authors:  Marina Korotkova; Ingrid E Lundberg
Journal:  Nat Rev Rheumatol       Date:  2014-01-28       Impact factor: 20.543

8.  Assessment of the potential role of muscle spindle mechanoreceptor afferents in chronic muscle pain in the rat masseter muscle.

Authors:  James P Lund; Somayeh Sadeghi; Tuija Athanassiadis; Nadia Caram Salas; François Auclair; Benoît Thivierge; Isabel Arsenault; Pierre Rompré; Karl-Gunnar Westberg; Arlette Kolta
Journal:  PLoS One       Date:  2010-06-15       Impact factor: 3.240

9.  Algesic agents exciting muscle nociceptors.

Authors:  S Mense
Journal:  Exp Brain Res       Date:  2009-01-13       Impact factor: 1.972

Review 10.  Emerging peripheral receptor targets for deep-tissue craniofacial pain therapies.

Authors:  R Ambalavanar; D Dessem
Journal:  J Dent Res       Date:  2009-03       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.